About Influenza A Virus Mouse Model
Creative Diagnostics' research team studies multiple influenza A strains, including H9N2, H1N1, and H3N2. The company offers clients a portfolio of customized and standardized preclinical services utilizing mouse infection models to evaluate pathogenic mechanisms, humoral immune responses, and protective efficacy induced by wild-type influenza A viruses or influenza vaccines. The mouse models include H9N2 Avian Influenza Mouse Model, H1N1 Strain Mouse Model, Pdm H1N1 Strain Mouse Model, and H3N2 Strain Mouse Model.
Phone
6313460027Reviews
No reviews yet. Be the first to share your experience!
Leave a Review
Send a Message
Get in touch with Influenza A Virus Mouse Model directly
More Research Labs
View all →Creative Bioarray
Creative Bioarray is an innovative biotechnology company whose mission focuses on developing unique technologies that provide global scientists with high quality products and satisfactory services to facilitate the investigation of life science researches.
Creative biogene
As a scientists-founded and scientists-driven leading biotechnological company, Creative Biogene focuses on developing high quality products and services, as well as proprietary technology to support the research in the field of basic life sciences research, biomedical development, industrial synthetic application and preclinical drug discovery.
Earthworm Microsomes
Creative Diagnostics' SpeX® Earthworm Microsome model is a crucial for studying drug metabolism and the environmental fate of pharmaceuticals within soil biocommunity systems. This model assists researchers in evaluating the environmental risks and ecotoxicity of pharmaceuticals. Additionally, the metabolic mechanisms of earthworms and mammalian intestines are highly similar (both are rich in CYP450 enzymes and transferases), making this novel product an ideal complementary model for mammalian drug metabolism research. It effectively simulates the first-pass metabolism of orally administered drugs and provides a vital tool for bioavailability studies. Most significantly, as a unique non-mammalian model, earthworm microsomes open new avenues for exploring novel metabolic pathways and drive innovation in drug metabolism research.